These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 30630422)

  • 1. Closing the gap - detection of clinically relevant von Willebrand disease in emergency settings through an improved algorithm based on rotational Thromboelastometry.
    Topf HG; Strasser ER; Breuer G; Rascher W; Rauh M; Fahlbusch FB
    BMC Anesthesiol; 2019 Jan; 19(1):10. PubMed ID: 30630422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective diagnostic accuracy study evaluating rotational thromboelastometry and thromboelastography in 100 patients with von Willebrand disease.
    Schmidt DE; Majeed A; Bruzelius M; Odeberg J; Holmström M; Ågren A
    Haemophilia; 2017 Mar; 23(2):309-318. PubMed ID: 27785858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective study of low-dose ristocetin-induced platelet aggregation to identify type 2B von Willebrand disease (VWD) and platelet-type VWD in children.
    Frontroth JP; Hepner M; Sciuccati G; Feliú Torres A; Pieroni G; Bonduel M
    Thromb Haemost; 2010 Dec; 104(6):1158-65. PubMed ID: 20941465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technological advances in diagnostic testing for von Willebrand disease: new approaches and challenges.
    Hayward CP; Moffat KA; Graf L
    Int J Lab Hematol; 2014 Jun; 36(3):334-40. PubMed ID: 24750680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of an automated method for measuring von Willebrand factor activity in clinical samples without ristocetin.
    Graf L; Moffat KA; Carlino SA; Chan AK; Iorio A; Giulivi A; Hayward CP
    Int J Lab Hematol; 2014 Jun; 36(3):341-51. PubMed ID: 24750681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a modified thromboelastography assay for the screening of von Willebrand disease.
    Topf HG; Weiss D; Lischetzki G; Strasser E; Rascher W; Rauh M
    Thromb Haemost; 2011 Jun; 105(6):1091-9. PubMed ID: 21505720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Von Willebrand factor (VWF) activity VWF:Ac with VWF ristocetin cofactor activity VWF:RCo.
    Geisen U; Zieger B; Nakamura L; Weis A; Heinz J; Michiels JJ; Heilmann C
    Thromb Res; 2014 Aug; 134(2):246-50. PubMed ID: 24891215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay.
    Dean JA; Blanchette VS; Carcao MD; Stain AM; Sparling CR; Siekmann J; Turecek PL; Lillicrap D; Rand ML
    Thromb Haemost; 2000 Sep; 84(3):401-9. PubMed ID: 11019962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of thromboelastography for the diagnosis of von Willebrand disease.
    Regling K; Kakulavarapu S; Thomas R; Hollon W; Chitlur MB
    Pediatr Blood Cancer; 2019 Jul; 66(7):e27714. PubMed ID: 30945453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What have we learned from large population studies of von Willebrand disease?
    Montgomery RR; Flood VH
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):670-677. PubMed ID: 27913545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole blood ristocetin-activated platelet impedance aggregometry (Multiplate) for the rapid detection of Von Willebrand disease.
    Schmidt DE; Bruzelius M; Majeed A; Odeberg J; Holmström M; Ågren A
    Thromb Haemost; 2017 Jul; 117(8):1528-1533. PubMed ID: 28692107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis or Exclusion of von Willebrand Disease Using Laboratory Testing.
    Favaloro EJ
    Methods Mol Biol; 2017; 1646():391-402. PubMed ID: 28804843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. von Willebrand disease: a laboratory approach.
    Trasi S; Ghosh K; Shetty S; Mohanty D
    Natl Med J India; 2005; 18(2):78-84. PubMed ID: 15981443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High resolution multimer analysis and the PFA-100 platelet function analyser can detect von Willebrand disease type 2A without a pathological ratio of ristocetin cofactor activity and von Willebrand antigen level.
    Weiss DR; Strasser EF; Ringwald J; Zimmermann R; Eckstein R
    Clin Lab; 2012; 58(11-12):1203-9. PubMed ID: 23289190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole blood ristocetin-induced platelet impedance aggregometry does not reflect clinical severity in patients with type 1 von Willebrand disease.
    Nakajima Y; Nogami K; Yada K; Ogiwara K; Furukawa S; Shimonishi N; Shima M
    Haemophilia; 2019 May; 25(3):e174-e179. PubMed ID: 30866149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Von Willebrand's disease: case report and review of literature.
    Echahdi H; El Hasbaoui B; El Khorassani M; Agadr A; Khattab M
    Pan Afr Med J; 2017; 27():147. PubMed ID: 28904675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory diagnosis and monitoring of desmopressin treatment of von Willebrand's disease by flow cytometry.
    Giannini S; Mezzasoma AM; Leone M; Gresele P
    Haematologica; 2007 Dec; 92(12):1647-54. PubMed ID: 18055988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of von Willebrand factor binding to a recombinant fragment of glycoprotein Ibalpha in an enzyme-linked immunosorbent assay-based method: performances in patients with type 2B von Willebrand disease.
    Caron C; Hilbert L; Vanhoorelbeke K; Deckmyn H; Goudemand J; Mazurier C
    Br J Haematol; 2006 Jun; 133(6):655-63. PubMed ID: 16704443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Utility of Thromboelastography in Monitoring Von Willebrand Disease: A Case Report.
    Al-Jumaili Z; Ibrahim N; Ahmed AA; Chang B; Wahed A; Mai B
    Ann Clin Lab Sci; 2024 Mar; 54(2):246-250. PubMed ID: 38802159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing Coagulation by Rotational Thromboelastometry (ROTEM) in Rivaroxaban-Anticoagulated Blood Using Hemostatic Agents.
    Bar J; David A; Khader T; Mulcare M; Tedeschi C
    Prehosp Disaster Med; 2017 Oct; 32(5):580-587. PubMed ID: 28625215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.